The prevalence of serious inflammatory safety issues such as cytokine release syndrome and immune effector cell–associated ...
The CEO of ModeX Therapeutics discusses MDX2003, a groundbreaking tetraspecific therapy that promises enhanced efficacy and ...
News-Medical.Net on MSN
Recent advances in CAR-NK cell therapy could revolutionze cancer treatment
Cell-based immunotherapies have transformed cancer treatment, yet their widespread use remains constrained by safety risks, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback